JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YONKMAN, F. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by YONKMAN, F. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 52, Issue 3, 290-296, 1934
Copyright © 1934 by American Society for Pharmacology and Experimental Therapeutics


INHIBITORY INNERVATION OF THE IRIS SPHINCTER

FREDRICK F. YONKMAN 1

1 From the Department of Pharmacology, Boston University School of Medicine, and the Evans Memorial of the Massachusetts Memorial Hospitals, Boston, Massachusetts

Evidence is presented that stimulation of the cervical sympathetic nerve or of its end-plates can produce in the corresponding eye a slight but significant dilatation of the pupil previously constricted to a slit by ergotoxine. Furthermore, this dilatation occurs more frequently if faradization immediately follows elimination of parasympathetic control of the sphincter by atropine. Since ergotoxine constriction is produced by paralysis of the motor sympathetic terminations in the dilator pupillae and by direct muscular action on the sphincter, dilatation under sympathomimetics or by faradization of the cervical sympathetic nerve can be explained either on the supposition that incomplete occlusion of motor sympathetic impulses had been produced by the dosage of ergotoxine employed, or on the supposition that this nerve exhibits an inhibitory effect on the iris sphincter.

From the data presented, the latter supposition seems most plausible. Thus, explanation of mydriasis under sympathomimetic agents necessitates the inclusion of inhibitory sympathetic innervation of the sphincter as well as motor sympathetic innervation of the dilator muscles of the iris.

Submitted on July 25, 1934







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1934 by the American Society for Pharmacology and Experimental Therapeutics.